Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure.
about
Spironolactone prescribing in heart failure: comparison between general medical patients and those attending a specialist left ventricular dysfunction clinicPharmacodynamic Impact of Carboxylesterase 1 Gene Variants in Patients with Congestive Heart Failure Treated with Angiotensin-Converting Enzyme InhibitorsAdiponectin deficiency, diastolic dysfunction, and diastolic heart failure.Why does spironolactone improve mortality over and above an ACE inhibitor in chronic heart failure?The Genetic Challenges and Opportunities in Advanced Heart FailureImportance of neuroendocrine activation in chronic heart failure. Impact on treatment strategies.Recent advances in the management of chronic heart failure.The past, present and future of renin-angiotensin aldosterone system inhibitionOral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience.Eplerenone--a novel selective aldosterone blocker.The causes, consequences, and treatment of left or right heart failureHeart failure and the brain: new perspectives.Screening for treatable left ventricular abnormalities in diabetic patients.Toward a broader understanding of aldosterone in congestive heart failure.Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular disease.Aldosterone receptor antagonists: biology and novel therapeutical applications.High-versus low-dose ACE inhibitor therapy in chronic heart failure.The role of angiotensin-converting enzyme polymorphism in congestive heart failure.Role of the selective aldosterone receptor blockers in arterial hypertension.Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failureNovel antihypertensive agents.Midkine Regulates BP through Cytochrome P450-Derived Eicosanoids.Diuretic usage in heart failure: a continuing conundrum in 2005.Differential effects of antihypertensive drugs on renal and glomerular hemodynamics and injury in the chronic nitric-oxide-suppressed rat.Adverse cardiorenal effects of aldosterone: is aldosterone antagonism beneficial?Novel strategies: challenge loop diuretics and sodium management in heart failure--Part I.Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers.A randomised, controlled, double-blind, cross-over pilot study assessing the effects of spironolactone, losartan and their combination on heart rate variability and QT dispersion in patients with chronic heart failure.Aldosterone antagonists in heart failure.Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes.CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure.Eplerenone for the treatment of cardiovascular disorders.Targeting the renin-angiotensin-aldosterone system in heart failure.New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease.Effect of spironolactone combined with angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers on chronic glomerular disease.Acute effects of aldosterone on the autonomic nervous system and the baroreflex function in healthy humans.Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy.Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone.Congestive heart failure due to systolic dysfunction: the Cinderella of cardiovascular management in dialysis patients.Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension.
P2860
Q28345144-42A7B463-55C6-475B-81F1-4F49DA86CD25Q28554328-59A790EF-8F03-49B0-8154-8130D338770DQ33511929-E022D01F-0C02-43A4-ADBB-E016497E0589Q33640255-88286CE9-3C00-4086-B7A0-9F31198448F8Q33653498-8A02F9F9-6594-4541-ADB0-4A3A911C98D1Q33999920-85013AEF-A73E-48E3-AD2C-8E37B8B88163Q34031741-8ADB88BA-2FAE-48A1-939F-1F6C1DB45637Q34094354-EC02FF85-FC3A-44AF-8551-1ED7D6833D7FQ34216716-88B5208F-44C1-4965-A418-9B3544A9D015Q34874363-85DDCF50-3F5B-4306-90DC-EB0B8D9DADBAQ34987168-D6DB8ADD-0D1E-442F-A365-091C08A787E8Q35046024-FC9175EB-0705-4E8F-A267-62FE7771AB5CQ35116162-4CCA5CF0-CA54-4CD0-9464-DA4755404753Q35580139-0727DAAA-F1DD-4861-8B68-3D180E671F14Q35580143-B4FCE26B-A0FD-45F5-BA7C-464D446A1046Q35605655-3A6EA639-BF12-4D8D-A6DF-63671F02C6D1Q35693765-9EDFD145-0A2D-432B-BCE1-707D6AC2EA9CQ35741732-292FFA10-35B7-41F5-B5FE-77FF15CD3303Q35770241-8C3D0244-3D57-4624-856F-7351A8DB8044Q35772010-1CDCA48F-AF35-4F25-B51A-7615584B3CEDQ35842537-52501FD7-C526-4E5B-8529-9E0A7EC47EA9Q35903066-BD99AA28-488F-4991-94E3-D3596320C555Q36056333-34B528BE-C959-4788-955D-93A572BA43FCQ36108475-F706F929-E47B-458B-A634-374194598E03Q36124918-9619812B-40A1-4C92-A0B6-2C7DB5F9F955Q36773341-A2EA4B26-5DFE-4239-8D0D-BC7668EF433EQ37199205-923C2770-813D-4A27-BED6-B62D3ECCD8E9Q37677353-9A2FD1B1-5BE8-456B-9B6C-0E36DB18871CQ37821172-897EA179-D9B7-4922-80FE-29E476CDAE8CQ37889518-C206BB87-90B1-484C-BA5C-98555EA9794AQ37911729-4C68EC7F-FC38-401C-8DAD-B2CC14B45792Q38036328-D1858765-A0EC-4AE8-875E-C9D0F0585651Q38074092-67E6E7F3-C043-4039-A4CC-8A9E020DDF05Q38845433-2C332CF7-221D-4F7E-8DC7-9FAC3F7686BCQ41773994-D9464BCB-0850-42D1-BE65-136CF8DA208CQ42489524-9DCC3630-F141-41E1-B7F4-DAE520F77B31Q43558447-FE28408B-7B67-4D3D-80BA-5F470CAF3553Q44009660-467221E2-CA55-4682-A9E5-B22D8E5A4B9FQ44052018-F2526857-A0E0-4F71-B2F1-794727B1B5A1Q44087722-2403D82E-D3F8-4CCD-A6D4-7050A7EF9999
P2860
Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Aldosterone escape during angi ...... rapy in chronic heart failure.
@en
type
label
Aldosterone escape during angi ...... rapy in chronic heart failure.
@en
prefLabel
Aldosterone escape during angi ...... rapy in chronic heart failure.
@en
P1476
Aldosterone escape during angi ...... rapy in chronic heart failure.
@en
P2093
Struthers AD
P356
10.1016/S1071-9164(96)80009-1
P577
1996-03-01T00:00:00Z